Surgical Site Infections Market

ASEAN Surgical Site Infections Market Outlook 2031

• The surgical site infections market in ASEAN was valued at US$ 137 Mn in 2021
• The market in the region is projected to grow at a CAGR of 6.5% from 2022 to 2031
• The surgical site infections market in ASEAN is anticipated to reach more than US$ 251 Mn by the end of 2031

Analysts’ Viewpoint on Surgical Site Infections Market Scenario

Surgical site infections (SSIs) represent a substantial clinical and economic burden on patients and the healthcare system. Hence, the surgical site infections market in ASEAN is expected to witness moderate growth during the forecast period. Implementation of an effective surveillance program and increase in technologically advanced surgical products are likely to boost the growth of the surgical site infections market in ASEAN. Companies in the market are focusing on technological advancements in devices to keep businesses growing post the COVID-19 pandemic.

Overview of ASEAN Surgical Site Infections Market

Surgical site infection occurs about 30 days or up to one year after surgery in patients who receive implants, and affects either the cut or deep tissue at the surgical site. These infections are quite hazardous and can be superficial involving the skin, but could involve subcutaneous tissue, organs, or implants as well.

Organ or space infection involves any part of the anatomy other than the incision that is opened or manipulated during the surgical procedure such as joint or peritoneum. These infections could be indicated by the drainage of pus or the formation of an abscess detected by histo-pathological or radiological examination or during re-operation.

Surgical site infections are the second-most common issue associated with hospitalized patients who have undergone surgery. Surgical site infections generally increase the days of hospitalization and medication bills, as also morbidity and mortality. The surgical procedure, sterilization methods, and aseptic surgical area are modified according to the prevention of surgical site infection guidelines to prevent surgical site infections.

SSIs represent a substantial clinical and economic burden on patients and the healthcare system, primarily attributed to increase in morbidity, mortality, and hospital expenditure. An article published in the journal ‘Infection, Disease & Health' stated that, in Asia, the additional cost due to SSI treatment is estimated to vary between US$ 396 and US$ 5,237 Mn.

Surgical site infections occur in 2% to 4% of all patients undergoing surgical procedures. Most of these infections are treatable with antibiotics; however, SSIs are major causes of morbidity and mortality after surgery. Hence, increase in the incidence rate of surgical site infections is projected to boost the growth of the surgical site infections market in ASEAN.

Request a sample to get extensive insights into the ASEAN Surgical Site Infections Market

Increase in Incidence Rate of Surgical Site Infections to Propel Market

Increase in incidence of surgical site infections augments the surgical site infection market in ASEAN. SSIs occur in around 5% of all patients undergoing inpatient surgical procedures. Most infections are treatable with antibiotics; however, SSI is a significant cause of morbidity and mortality after surgery. For instance, Wong and Holloway stated that in a general surgery department at a general hospital in Malaysia, SSI incidence was 11.7%.

According to Infection Control & Hospital Epidemiology, significant SSI rate was found in categories of wounds such as clean wounds, clean-contaminated, contaminated, and dirty wounds. The lowest rate of SSI was found in obstetric-gynecologic procedures and the highest rate in cardiothoracic operations. Surgical site infections (SSIs) are the second most common type of healthcare-associated infections (HAIs). Therefore, increase in the incidence of surgical site infections is projected to drive the surgical site infections market in ASEAN during the forecast period.

Rise in Number of Surgical Procedures to Propel ASEAN Market

The rise in injury cases is a key factor propelling the demand for surgeries. Road accidents have increased considerably in countries of Asia Pacific. According to a survey conducted by the University of Michigan’s Transportation Research Institute, Thailand ranked second in road fatalities globally, with 44 road deaths per 100,000 people.

An alarming number of traumatic brain injury cases have been reported in countries such as Thailand, India, Australia, China, and Malaysia, which can be the reason for the growth of the surgical site infection market.

In addition, rise in the number of surgical procedures propels the surgical site infection market in ASEAN. For instance, in 2020, rhinoplasty was the most common surgical procedure performed in Thailand, with around 21,100 performed procedures, followed by eyelid surgery and breast augmentation. In the same year, the total surgical procedures in the country stood at around 102,400.

Request a custom report on ASEAN Surgical Site Infections Market

Technological Advancements to Boost Demand for SSI Products

Technologically advanced products are likely to dominate the surgical site infection market in ASEAN over the next few years. Improvement in strength, durability, protection, and permeability enables non-woven surgical devices to be used in various surgical procedures at a much lower cost than others. For instance, Ahlstrom TrustShield offers an extensive range of high-performance fabrics for surgical drapes, which are absorbent to ensure a cleaner operating, repellent to avoid fluid penetration in low fluid surgeries, and impervious - a total barrier to bacteria and viruses.

The TYRX Absorbable Antibacterial Envelope is designed for use with cardiac implantable electronic devices (CIEDs), including implantable cardioverter defibrillators (ICDs), and pacemakers.

Rise in Prep-op Skin Preparation to Prevent Surgical Site Infections

In terms of type, the surgical site infections market in ASEAN has been bifurcated into prep-op skin preparation and intra-op skin preparation. The prep-op skin preparation segment dominated the surgical site infections market in the region in 2020. The trend is anticipated to continue during the forecast period due to rise in awareness about surgical site infections that lead to significant clinical problems and increase in hospital stay.

The intra-op skin preparation segment is driven by increase in investment in research & development by countries in ASEAN and diversification of product portfolio by key players.

Hospital Wards Segment to Capture Largest Market Share

Based on end-user, the surgical site infections market in ASEAN has been divided into hospital operating rooms, hospital wards, ambulatory surgical centers, intensive care units, and specialty clinics. The hospital wards segment led the market in the region in 2021 due to increase in the number of hospitals and improvement in healthcare infrastructure.

The hospital operating rooms segment is likely to be driven by increase in the incidence of chronic diseases, rise in the number of surgical procedures, and surge in the geriatric population.

Regional Outlook of ASEAN Surgical Site Infection Market

Road accidents have increased considerably in countries in Asia Pacific. A large number of traumatic brain injury cases have been reported in Thailand, India, Australia, China, Indonesia, and Malaysia. Therefore, increase in the number of surgeries drives the surgical site infections market in ASEAN.

Indonesia dominated the surgical site infection (SSI) market in ASEAN, accounting for around 23% share in 2021. The trend is projected to continue during the forecast period. Rise in surgical procedures and increase in the geriatric population can be attributed to the country’s large market share.

Thailand was the fastest growing market for surgical site infection treatment in ASEAN in 2021. The market in the country is likely to grow at a CAGR of 6% during the forecast period.

Competition Landscape of ASEAN Surgical Site Infections Market

The surgical site infections market in ASEAN is consolidated, with a small number of leading players accounting for major market share. Most companies are making significant investments in research and development.

The growth of product portfolio and mergers & acquisitions are the key strategies adopted by the players. The surgical site infections market in ASEAN is fragmented due to the presence of a large number of players. Key players operating in the market include 3M, BD, Cardinal Health, ME Medical AG, B. Braun Melsungen AG, Stryker, and TYRX, Inc. (Medtronic).

Each of these players has been profiled in the surgical site infections market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in ASEAN Surgical Site Infections Market

In March 2022, in order to minimize the possibility of contamination, which can lead to SSIs, Cardinal Health developed a new and unique technology, the Cardinal Health CHG surgical incise drapes with BeneHold CHG adhesive technology.

In August 2018, 3M Company introduced its new product, SoluPrep Film-Forming Sterile Surgical Solution, which is a skin preparation solution. The company declared that the new surgical infection control product is a 2% chlorhexidine gluconate and 70% isopropyl alcohol surgical skin preparation solution, which uses 3M’s polymer and adhesive technology and can be used to fight against surgical site infections.

ASEAN Surgical Site Infections Market Snapshot